Intravenous Infusions Plc announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was GHS 23.085 million compared to GHS 20.206 million a year ago. Net income was GHS 1.870 million compared to GHS 2.842 million a year ago. Basic earnings per share was GHS 0.0073 compared to GHS 0.01254 a year ago.